Delivery Order SPE2DB22D3004-SPE2DB25FQ94C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,127.41 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,695.44 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and was awarded competitively. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.56 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,267.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.67 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 30 mg capsules (100 count) valued at $1,840.35. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Dextroamphetamine ER 10 mg capsules (90-count supply) valued at $1,149.48, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $1,216.66 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on September 4, 2025, with an ultimate completion date of September 5, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) with a ceiling value of $1,473.61. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ94CDelivery Order
AmerisourceBergen Drug Corp has been awarded a $1,592.96 delivery order by the Defense Logistics Agency (DLA) for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with a completion date of September 29, 2025. The award is a competitively procured, firm fixed-price contract with no set-aside designation. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's substantial IDC with the DLA demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. The current delivery order reflects the company's ongoing role as a key supplier of both brand-name and generic medications to federal healthcare entities through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/26/25 |